Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
26,021
-
Share change
-
+1,320
-
Total reported value
-
$111,630
-
Price per share
-
$4.29
-
Number of holders
-
1
-
Value change
-
+$5,663
-
Number of buys
-
1
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2023
As of 31 Dec 2023 SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,021 shares of stock of the company.
Largest 10 holders included BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, Rubric Capital Management LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Kynam Capital Management, LP, BAILLIE GIFFORD & CO, and Samsara BioCapital, LLC.
This table shows 113 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.